Associations between cytokine levels and cognitive function among individuals at clinical high risk for psychosis
TianHong Zhang,Xing Chen,YanYan Wei,XiaoChen Tang,LiHua Xu,HuiRu Cui,HaiChun Liu,ZiXuan Wang,Tao Chen,ChunBo Li,JiJun Wang
DOI: https://doi.org/10.1016/j.pnpbp.2024.111166
IF: 5.201
2024-10-11
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Abstract:Objective To explore the intricate interplay among cytokines, cognitive functioning, and conversion to psychosis in individuals at clinical high-risk (CHR) for psychosis. Method We initially enrolled 385 individuals at CHR and 95 healthy controls (HCs). Subsequently, 102 participants at CHR completed the 1-year follow-up assessments, and 47 participants transitioned to psychosis. We assessed the levels of interleukins (IL-1β, IL-2, IL-6, IL-8, IL-10), tumor necrosis factor-α (TNF-α), granulocyte-macrophage colony-stimulating factor (GM-CSF), and vascular endothelial growth factor (VEGF). We comprehensively evaluated cognitive performance across six domains, including speed of processing (SP), attention/vigilance (AV), working memory (WM), verbal learning (VeL), visual learning (ViL), and reasoning and problem-solving (RPS). Results Higher baseline cognitive domain scores were associated with elevated GM-CSF and reduced VEGF levels. In the follow-up analysis, significant time effects were observed for IL-1β and IL-2. We also observed significant interaction effects between specific cognitive domains (AV, WM, VeL, and OCS) and levels of cytokine (GM-CSF, IL-1β, IL-6, and TNF-α). Changes in WM were negatively correlated with changes in TNF-α levels and positively correlated with changes in VEGF levels. Variations in VeL were inversely correlated with changes in GM-CSF and IL-10 levels, whereas changes in RPS were positively associated with changes in GM-CSF and IL-8 levels. Conclusions Our results revealed intricate associations among cytokine levels, cognitive performance, and psychosis progression.
pharmacology & pharmacy,neurosciences,psychiatry,clinical neurology